MedPath

Comparison of Postoperative Outcome of Hepatectomy for Living Donors According to Three Different Incision

Completed
Conditions
Healthy Donors for Liver Transplantation
Interventions
Procedure: hepatectomy midline incision
Procedure: hepatectomy conventional incision
Procedure: hepatectomy transverse incision
Registration Number
NCT02413983
Lead Sponsor
Samsung Medical Center
Brief Summary

Living donor liver transplantation (LDLT) is an important option for patients with end-stage liver disease requiring liver transplantation. When performing LDLT, the safety and well being of donors is of the utmost importance. The conventional incision for donor hepatectomy is a right subcostal incision with a midline extension up to xiphoid. Minimally invasive liver surgery throughout a single 10 cm upper midline incision without laparoscopic assistance has been widely applied and considered to be safe and effective. Recently, laparoscopic and minimally invasive living donor hepatectomy via transverse incision has been suggested to reduce morbidity and the invasiveness of living donor hepatectomy. Although minimally invasive approach has become the surgical method of choice for many transplant centers, little data on comparing the impact of all three different type incision in living liver donors. In our center, the investigators have adopted three different incision according to surgical teams. The investigators undertook this study with the aims of comparing the pain and quality of life of donors according to type of three different incisions and assessing any benefits to the donor due to the smaller midline incision during the early postoperative period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • ASA (American Society of Anesthesiologists) physical status I-II,
  • adult undergoing hepatectomy for living donors
Read More
Exclusion Criteria
  • known allergy to any of the drugs used in this study,
  • bleeding diathesis,
  • neurologic dysfunction (preexisting lower limb neurological deficit),
  • recent systemic or local infections,
  • history of drug use, or
  • under treatment with opioids because of chronic pain
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
MI (midline incision)hepatectomy midline incisionThe living liver donors underwent hepatectomy using upper midline incision (10cm) without laparoscopic assistance
CI (conventional incision)hepatectomy conventional incisionThe living liver donors underwent hepatectomy using right subcostal incision with a midline extension (conventional incision)
TI (transverse incision)hepatectomy transverse incisionThe living liver donors underwent hepatectomy using transverse incision with laparosocpic assistance
Primary Outcome Measures
NameTimeMethod
donor recovery/quality of life (as measure bye the quality of recovery [OoR] score)postoperative 7 day

QoR (quality of recovery) -15, has recently been developed, which can provide an extensive yet efficient evaluation of postoperative recovery from the patient's perspective \[8\]. The QoR-15 is an abbreviation of the longer and more comprehensive QoR-40 \[15\], and includes questions on pain, physical comfort, physical independence, psychological support and emotional state, and can be completed in approximately 2 minutes.

Secondary Outcome Measures
NameTimeMethod
donor recovery/quality of life (as measure bye the quality of recovery [OoR] score)postoperative 30 day

QoR (quality of recovery) -15, has recently been developed, which can provide an extensive yet efficient evaluation of postoperative recovery from the patient's perspective \[8\]. The QoR-15 is an abbreviation of the longer and more comprehensive QoR-40 \[15\], and includes questions on pain, physical comfort, physical independence, psychological support and emotional state, and can be completed in approximately 2 minutes.

assessment of subjective pain (as measured by numeric rating scale [NRS]) on postoperative day1, 4, 8, 24, 48 and 72 h after surgery

numeric rating scale (NRS) in which; 0 = no pain and 100 = worst pain

consumption of analgesics on postoperative day1, 4, 8, 24, 48 and 72 h after surgery
side effects (nausea, vomiting, back pain, pruritus)1, 4, 8, 24, 48 and 72 h after surgery

nausea, vomiting, back pain, pruritus

discomfort related to the scarpostoperative 30 day

abdominal wall sensorineural deficits (numbness and differences in tactile and temperature sensations) and tightness around the scar

Trial Locations

Locations (1)

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath